Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.

Livingston KA, Rosen JB, Zucker JR, Zimmerman CM.

Vaccine. 2014 Jan 9;32(3):369-74. doi: 10.1016/j.vaccine.2013.11.021. Epub 2013 Nov 16.

PMID:
24252695
2.

Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.

Chang C, Mo X, Hu P, Liang W, Ma H, An Z, Liu J, Zheng H.

Vaccine. 2015 Jun 22;33(28):3223-7. doi: 10.1016/j.vaccine.2015.04.083. Epub 2015 May 16.

PMID:
25989448
3.

Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.

Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW.

Clin Infect Dis. 2006 Feb 1;42(3):315-9. Epub 2005 Dec 15.

PMID:
16392073
4.

Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP.

Pediatr Infect Dis J. 2013 Apr;32(4):374-80. doi: 10.1097/INF.0b013e318279f593.

PMID:
23099425
5.

An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS.

CMAJ. 2011 Jun 14;183(9):1014-20. doi: 10.1503/cmaj.101371. Epub 2011 May 16.

6.

Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.

Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K.

Pediatrics. 2012 Dec;130(6):e1567-74. doi: 10.1542/peds.2012-0177. Epub 2012 Nov 5.

7.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD004407. doi: 10.1002/14651858.CD004407.pub3. Review.

PMID:
22336803
8.

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME.

Emerg Infect Dis. 2007 Jan;13(1):12-7.

9.

Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008.

Snijders BE, van Lier A, van de Kassteele J, Fanoy EB, Ruijs WL, Hulshof F, Blauwhof A, Schipper M, van Binnendijk R, Boot HJ, de Melker HE, Hahné SJ.

Vaccine. 2012 Apr 19;30(19):2999-3002. doi: 10.1016/j.vaccine.2012.02.035. Epub 2012 Feb 27.

PMID:
22381073
10.

An outbreak of mumps in the metropolitan area of Walsall, UK.

Pugh RN, Akinosi B, Pooransingh S, Kumar J, Grant S, Livesley E, Linnane J, Ramaiah S.

Int J Infect Dis. 2002 Dec;6(4):283-7.

PMID:
12718822
11.

Mumps vaccine performance among university students during a mumps outbreak.

Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan GH.

Clin Infect Dis. 2008 Apr 15;46(8):1172-80. doi: 10.1086/529141.

PMID:
18444852
12.

Re: Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.

Rau CJ, Danovaro-Holliday MC.

Vaccine. 2015 Jun 26;33(29):3273. doi: 10.1016/j.vaccine.2014.09.005. Epub 2014 Oct 1. No abstract available.

PMID:
25281769
13.

Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.

Takla A, Böhmer MM, Klinc C, Kurz N, Schaffer A, Stich H, Stöcker P, Wichmann O, Koch J.

Hum Vaccin Immunother. 2014;10(1):140-5. doi: 10.4161/hv.26642. Epub 2013 Oct 7.

14.

Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA.

Fiebelkorn AP, Lawler J, Curns AT, Brandeburg C, Wallace GS.

Emerg Infect Dis. 2013;19(9):1411-7. doi: 10.3201/eid1909.130299.

15.

Mumps outbreak in the Republic of Moldova, 2007-2008.

Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, an der Heiden M, Andrews N, Pebody R, Aidyralieva C, Hahné S.

Pediatr Infect Dis J. 2010 Aug;29(8):703-6. doi: 10.1097/INF.0b013e3181d743df.

PMID:
20308934
16.

Ongoing outbreak of mumps infection in Oban, Scotland, November 2010 to January 2011.

Walker J, Huc S, Sinka K, Tissington A, Oates K.

Euro Surveill. 2011 Feb 24;16(8). pii: 19803.

17.

Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.

Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.

PLoS One. 2014 Feb 20;9(2):e89361. doi: 10.1371/journal.pone.0089361. eCollection 2014.

18.

Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010.

Fiebelkorn AP, Rosen JB, Brown C, Zimmerman CM, Renshowitz H, D'Andrea C, Gallagher KM, Harpaz R, Zucker JR.

Hum Vaccin Immunother. 2013 Jan;9(1):189-94. doi: 10.4161/hv.22415.

19.

Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G.

Hum Vaccin Immunother. 2015;11(6):1413-7. doi: 10.1080/21645515.2015.1021522.

20.

Healthcare workers and measles-mumps-rubella (MMR) status: how worried should we be about further outbreaks?

Basu S, Giri P, Adisesh A, McNAUGHT R.

Epidemiol Infect. 2014 Aug;142(8):1688-94. doi: 10.1017/S0950268813002859. Epub 2013 Nov 14.

PMID:
24229805

Supplemental Content

Support Center